Synergistic association of metabolic syndrome and overt nephropathy with elevated asymmetric dimethylarginine in serum and impaired cutaneous microvasodilation in patients with type 2 diabetes.
Yamamoto
Ruriko
R
Department of Internal Medicine, Koshigaya Hospital, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan.
Aso
Yoshimasa
Y
D000419:Albuminuria; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000097:blood / Q000503:physiopathology*; D005260:Female; D005528:Foot / Q000098:blood supply; D006358:Hot Temperature; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000503:physiopathology*; D008875:Middle Aged; D015999:Multivariate Analysis; D018180:Thrombomodulin / Q000097:blood; D014664:Vasodilation / Q000502:physiology*
D008076:Cholesterol, HDL; D018180:Thrombomodulin; C487735:dimethylarginine; D001120:Arginine; D003404:Creatinine